NCT04337580 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04337580
Title	Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer (FASN)
Acronym	FASN
Recruitment	Recruiting
Gender	male
Phase	Phase II
Variant Requirements	No
Sponsors	Wake Forest University Health Sciences
Indications	prostate cancer
Therapies	Cabazitaxel + Omeprazole Docetaxel + Omeprazole
Age Groups:	adult \| senior
Covered Countries	USA

Filter rows:

Showing 1 to 2 of 2 entries

Facility	Status	City	State	Zip	Country	Details
W.G. Bill Hefner VA Medical Center	RECRUITING	Salisbury	North Carolina	28144	United States	Details
Wake Forest Baptist Comprehensive Cancer Center	RECRUITING	Winston-Salem	North Carolina	27157	United States	Details

Showing 1 to 2 of 2 entries

Filter rows:

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT04337580Clinical Trial Detail